Cargando…
Use of Botulinum Toxin A to Treat Chemotherapy-Induced Raynaud’s Phenomenon
Raynaud’s phenomenon (RP) is a vasospastic disorder of the digital blood vessels leading to pain, paresthesias, and pallor in response to cold or stress. RP can develop secondary to a number of pathologies or factors, including the use of chemotherapy agents. Typical first-line therapies for seconda...
Autores principales: | Potluri, Thrisha K, Lee, Frank G, Song, Ethan, Wallace, Sean J, Miller, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863048/ https://www.ncbi.nlm.nih.gov/pubmed/33564517 http://dx.doi.org/10.7759/cureus.12511 |
Ejemplares similares
-
Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review
por: Żebryk, Paweł, et al.
Publicado: (2015) -
Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections
por: Kim, Daniel J., et al.
Publicado: (2022) -
Reversed Palmaris Longus: A Rare Anatomical Phenomenon Discovered
por: Behiery, Ayman, et al.
Publicado: (2023) -
Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review
por: Cai, Ruyi, et al.
Publicado: (2022) -
Cocaine-Induced Raynaud's Phenomenon: A Case Report
por: Ahn, Heong Jin C, et al.
Publicado: (2023)